A Study Investigating Properties of the Transversus Abdominis Plane Block

Hillerod Hospital, Denmark

Status: Completed

Conditions: Anesthesia, Local

Treatments: Drug: Ropivacaine

Study type: Interventional

Funder types: Other

Identifiers

NCT01679392

2011-004719-22 (EudraCT Number)

H-1-2011-030

Details and patient eligibility

About

In this study we investigate the following properties of the transversus abdominis plane block in healthy volunteers:

1. Cutaneous analgesic distribution
2. Muscular affection
3. Reproducibility

Enrollment: 16 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Capable
• American society of anesthesiologists classification 1 or 2
• Written informed consent

Exclusion criteria

• Age below 18 years
• American society of anesthesiologists classification above 2
• Body weight below 50 kg
• Body mass index > 35 kg/m2
• Previous abdominal surgery
• Acute or chronic pain
• Use of pain medication less than 24 h prior to study start
• Allergy to local anesthetics
• Pregnancy
• Breastfeeding

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Quadruple Blind

---

16 participants in 1 patient group

Ropivacaine

Experimental group

Description:

Unilateral transversus abdominis plane block with 20 ml ropivacaine (7.5 mg/ml)

Treatment:

Drug: Ropivacaine